CLINICAL_TRIALS ClinicalTrials.gov record update

Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02099864
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:13.167685+00:00
Published At: 2021-01-13T00:00:00+00:00
Record Updated At: 2024-09-19
Results Posted At: 2021-01-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Castration-Resistant Prostate Carcinoma", "Metastatic Malignant Neoplasm in the Bone", "Metastatic Malignant Neoplasm in the Soft Tissues", "Metastatic Prostate Adenocarcinoma", "Recurrent Prostate Carcinoma", "Stage III Prostate Adenocarcinoma AJCC v7", "Stage IV Prostate Adenocarcinoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-09-19"
protocolSection.identificationModule.nctId: "NCT02099864"
protocolSection.identificationModule.officialTitle: "Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-01-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.